Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Merker

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 7, 2016
Health-related Quality of Life of Individuals With Neurofibromatosis Type 2: Results From the NF2 Natural History StudyVanessa L Merker, Amanda L Bergner, Ana-Maria Vranceanu, et al.
BMC Health Services Research|August 31, 2018
Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosisVanessa L Merker, Annie Dai, Heather B Radtke, et al.
Neurology|July 25, 2016
Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCTAna-Maria Vranceanu, Eric Riklin, Vanessa L Merker, et al.
Patient Education and Counseling|October 14, 2020
Effective provider-patient communication of a rare disease diagnosis: A qualitative study of people diagnosed with schwannomatosisVanessa L Merker, Scott R Plotkin, Martin P Charns, et al.
Journal of General Internal Medicine|March 13, 2026
Qualitative Methods for Clinical and Health Services Research in Internal Medicine: Guidance and Key ConsiderationsRachel Vanderkruik, Lara Traeger, Colleen B McGrath, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 5, 2025
A patient-centric approach to neuro-recovery after acute brain injuriesMuhammad Aemaz Ur Rehman, Kristi Emerson, Vanessa L Merker, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
Development and Initial Validation of the Quality of life Evaluation in <i>NF2</i> -related Schwannomatosis Trials (QUEST) AssessmentVanessa L Merker, Sophia C Carias, Rosalie E Ferner, et al.
Orphanet Journal of Rare Diseases|February 11, 2022
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialistsVanessa L Merker, Pamela Knight, Heather B Radtke, et al.
Fertility and Sterility|January 6, 2015
Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1Vanessa L Merker, Timothy P Murphy, J Bryan Hughes, et al.
Acta Neurologica Scandinavica|September 16, 2015
Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2S Farschtschi, V L Merker, D Wolf, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 7, 2016
Health-related Quality of Life of Individuals With Neurofibromatosis Type 2: Results From the NF2 Natural History StudyVanessa L Merker, Amanda L Bergner, Ana-Maria Vranceanu, et al.
BMC Health Services Research|August 31, 2018
Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosisVanessa L Merker, Annie Dai, Heather B Radtke, et al.
Neurology|July 25, 2016
Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCTAna-Maria Vranceanu, Eric Riklin, Vanessa L Merker, et al.
Patient Education and Counseling|October 14, 2020
Effective provider-patient communication of a rare disease diagnosis: A qualitative study of people diagnosed with schwannomatosisVanessa L Merker, Scott R Plotkin, Martin P Charns, et al.
Journal of General Internal Medicine|March 13, 2026
Qualitative Methods for Clinical and Health Services Research in Internal Medicine: Guidance and Key ConsiderationsRachel Vanderkruik, Lara Traeger, Colleen B McGrath, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 5, 2025
A patient-centric approach to neuro-recovery after acute brain injuriesMuhammad Aemaz Ur Rehman, Kristi Emerson, Vanessa L Merker, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
Development and Initial Validation of the Quality of life Evaluation in <i>NF2</i> -related Schwannomatosis Trials (QUEST) AssessmentVanessa L Merker, Sophia C Carias, Rosalie E Ferner, et al.
Orphanet Journal of Rare Diseases|February 11, 2022
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialistsVanessa L Merker, Pamela Knight, Heather B Radtke, et al.
Fertility and Sterility|January 6, 2015
Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1Vanessa L Merker, Timothy P Murphy, J Bryan Hughes, et al.
Acta Neurologica Scandinavica|September 16, 2015
Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2S Farschtschi, V L Merker, D Wolf, et al.
Pageof 8